Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 

Letter From The Editor

Letter from the Editor, #739

Each year when I talk to educators about the AADE meeting, I often find out that they can't go because it is not their year. For most of them this means that their employer is only sending one or two educators a year and it is not their turn. If...


Editor's Note, DCMS #198

The mixing up of mixed insulins can cause problems for some of our patients especially if they are trying to achieve the best control possible. This week our Disaster Averted looks at


Editor's Note, Special GLP-1 Edition, July 2014

We know that patients lose a great deal of weight after bariatric surgery. Often times some of the weight comes off fast in the beginning and then slowly after that. More importantly these patients have a quick resolution of hyperglycemia and...



Letter from the Editor, #738: Afrezza

After a long battle and comments from many doubters the FDA has approved the inhaled insulin, Afrezza. As soon as the approval came the nay-sayers were quick to remind us of what a failure Exubera had been and there was no way that this new inhaled...


Editor's Note, DCMS #197

For the past year we have been providing you with a monthly white paper on SGLT-2 inhibitors and for the past 7 weeks we have...


Editor's Note, SGLT2-Inhibitor Special Edition, July 2014

When the first SGLT-2 inhibitor came to the market we went to doctors all over the country and asked them their opinions on this new class of drugs. The overwhelming response was "wait and see." Now a year later we asked them again to...


Letter from the Editor #737

There was an article in Diabetologia 2014 stating that, "Whey protein may represent a novel approach for...


Editor's Note, DCMS #196

First it was the Quintessential Quintet, then the Setaceous Sextet, and Septicidal Septet was next in our discussion of causes of hyperglycemia -- now, this week in our Homerun Slides, we look at


Letter from the Editor, #736: High Blood Sugar Mystery

Can you all help me with a couple of things? I know from experience that many of our readers are very physically active and health conscious. In talking with some of my colleagues, many select lower carb regimens...


Insulin Special Edition, July 2014

For many years insulin has been looked at as a treatment of last resort for patients with type 2 diabetes and so patients can be highly resistant to exogenous insulin when they start on injections and this resistance often grows as they continue to...


Editor's Note, DCMS #195:

This week, our special text is our Comprehensive List of Insulins. The most comprehensive and up-to-date list available,...


Letter from the Editor #735

It is interesting to listen to PCP's and other prescribers talk about their reluctance to use GLP-1 analogs in their practice. This class of drugs had a great presence at this year's ADA Scientific Sessions and many of the posters and presentations...


Special Edition, GLP-1 Summer 2014

When Steve and Andrew got back from the scientific sessions in San Francisco we put together an awesome overview of some of the new research and...


Editor's Note, DCMS #194

For most of us the explanation of why our patients get type 2 diabetes has been boiled down to its simplest form: we put too much glucose in our cells which makes us resistant to moving glucose into the cells so the pancreas tries to compensate by...


Letter from the Editor #734

I was working with my calculator earlier (my abacus is broken) and figured out that each of you who reads this week's newsletter saves about $2300. Our publisher, Stephen Freed, spent all of his time finding the best and most interesting articles...


Editor's Note, SGLT-2 Inhibitors June Special Edition

There was a lot of activity at the ADA this year and considerable attention was focused on the SGLT2 inhibitors. This class of drugs, which includes the currently approved canagliflozin and dapagliflozin and the hopefully-soon-to-be-approved...


Editor's Note, GLP-1 Special Edition June 2014

The last time the ADA was in San Francisco was 2008, and there were only a few of us who had even heard of a GLP-1. This novel hormone for the first time had a synthetic duplication that could be used to help control glucose levels. This time when...


Editor's Note DCMS #193: Is it sugar free or isn’t it?

Sometimes life is too sweet to be true and in this week's Disaster Averted, our patient finds out how sweet life can get if you grab the wrong bottle off...


Letter from the Editor #733

This week there is a lot of press on the use of insulin right after metformin and...


Editor's Note, DCMS #192

On my way to the airport Monday morning I was listening to a feature on NPR's Morning Edition about the use of pharmacists in the ER and of course my ears perked up. They were discussing how many drug errors occur in the hospital and how over 7,000...


Letter from the Editor, #732

For many years we have been talking about the value of almonds, walnuts, and pistachios in our patients health. We have published over 75 articles on the way to maximize these foods. This week we have a great feature on...


Editor's Note, DCMS #191

There are a plethora of new shows available to viewers today, and many of them are mysteries where a murder or crime occurs, dedicated law enforcement officials work to find out who committed the crime, and then go about punishing them. This...


Letter from the Editor, #731:

This week there is a great item about diabetes and cardiovascular problems, especially in women. In fact there are a total of four items that continue to expound on the relationship between diabetes, obesity and cardiovascular Disease. To make...


GLP-1 Analog Special Edition, May 2014

Way back in July 2011 we reviewed some of the emerging data showing that the GLP-1 RA class might have some value in improving cardiovascular outcomes. As newer entities in this class have been researched the cardiovascular studies required for...


Editor's Note, DCMS #190:

Can you remember where the phrase, "Warning, Will Robinson, warning warning!" came from? This week we have a real warning list for you to pay attention to as the information from ISMP in our Disaster Averted looks at


Letter from the Editor, Issue #730:

Last month I worked with Bruce Biundo, RPh, FACA, and Jerry D. Meece, RPh, FACA, FAADE, CDM, CDE, to develop a CE program on testosterone for pharmacists. This CE, The...


Editor's Note, SGLT2 Special Edition, May 2014

If you do a search on our website you will find over 150 articles and slide series about the SGLT-2 inhibitors. The content ranges from research studies to patient cases,...


Editor's Note, DCMS #189: Ink-a Dinka Don't

Years ago there was a famous singer, actor, and comedian, Jimmy Durante, who would often start or end a joke with the phrase "ink-a dinka doo." However, after you read this week's 


Letter from the Editor #729

On Friday morning after I got done with a 40 mile bike ride with our local club, we were sitting and talking at our favorite coffee shop when my phone rang. It was a family friend who wanted to talk about her husband's medications for diabetes. He...


Editor's Note, DCMS #188

Each and every month we have been providing you with the best information on GLP-1 agonists with our monthly special editions. Many of you send me emails thanking us for the...


Letter from the Editor #728

We have a really interesting item this week that bears reading more than once. Item #4 talks about


Editor's Note, DCMS #187: Maximizing the Effectiveness of Medications

Weight management and diabetes are almost always mentioned in the same breath to our patients, but too often they really don't go together in the real world. This week in Part 7 of our latest Homerun Slides series,


Letter from the Editor #727

Often times our patients get so much information that they get frustrated and just give up. This means all our efforts go to waste and both the patient and practitioner are unhappy. Our health and wellness guru Dr. Sheri Colberg has been working...


Editor's Note, DCMS #186

Most clinicians focus on fasting glucose levels to prevent the complications of diabetes. What if there was a generic diabetes medication available that would lower ppg and cardiovascular risk and had almost no chance of causing hypoglycemia? If...


Letter from the Editor #726

Most of us have seen the benefits of testosterone supplementation for our patients with diabetes. We most often think of the increased muscle mass, and libido in our prescribing decision. This week a new study shows additional benefits of...


Editor's Note, DCMS #185

U-500 is a small word that causes a lot of fear in the hearts of some physicians, pharmacists and patients. This regular insulin marketed by Eli Lilly as Humulin R U-500 is without a doubt the hardest insulin to work with. Converting doses,...


Editor's Note, GLP-1 Analog Special Edition, April 2014

When we sit down with our patients to talk about starting on GLP-1 analogs, we usually explain the main ways that they work. These are usually decreased glucagon release, less glucose dumping from the liver, increased and faster insulin secretion,...


Letter from the Editor #725

This past week I was in the corporate office of one of the most successful ACO's in the country meeting with members of their diabetes initiative project. As you know, improvement in A1c's is a major grading point for 5-star quality ratings and...


Special Edition, SGLT2 Inhibitors, April 2014

The role of the kidneys are becoming very well known in the Ominous Octet of Diabetes. The SGLT2 receptor on the kidneys is a new target for novel treatments of diabetes. This month we have a set of very well done slides from the Worldwide...


Editor's Note, DCMS #184

How would you feel if your 85-year-old mother or grandmother got a call from her hospital that she needed to get an HIV and hepatitis test? This might have happened to her if she was one of over 4,200 patients in a Long Island hospital where they...



Navigate through our listing of Letter From The Editor articles here.
Next Last

524 Total articles for Letter From The Editor


Browse our other news categories below.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Looking for a particular Newsletter Issue? Click Here

Cast Your Vote
Do you offer group education sessions in your practice?
CME/CE of the Week
Lawrence Lavery, DPM, MPH

Category: Wound Care
Credits: .75


Advertisement


Search Articles On Diabetes In Control